CROS NT appoints MacGarvey as vice president

Wednesday, August 15, 2012 02:01 PM

CROS NT, an international CRO specializing in clinical data services, has appointed Andrew MacGarvey as the vice president of U.K. and U.S. operations.

MacGarvey brings for CROS NT 15 years experience in the pharmaceutical sector. With a strong background in programming and data management, he has worked in senior management and director roles for multiple CROs in Europe and the U.S. MacGarvey has experience in growing U.K.‐based operations, as well as establishing U.S. offices.

MacGarvey’s promotion comes as CROS NT expands into the U.K. by establishing CROS NT Limited and opening office space in Atterbury Lakes Business Park in Milton Keynes, just north of London.

 

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs